Pharma Cartons & Cartoning: Market Size & Forecast 2026

The global pharma cartons and cartoning category sits at approximately USD 9.2 billion in 2025 (base year), held in a balanced-to-tight demand-supply state where Solid Bleached Sulfate (SBS) paperboard availability, pharma-grade conversion qualification costs, and serialization mandates collectively shape procurement economics. Folding cartons account for roughly 58 percent of the category, with prescription oral solids commanding 48 percent of end-use demand. A 4.8 percent CAGR through 2032 carries the market to approximately USD 12.8 billion by the forecast year, driven by biologics growth, serialization infrastructure build-out, and packaging-waste regulation compliance. > **Analyst Take.** The boring real-world reason pharma cartons are under-owned by procurement strategy teams is that the category looks commoditised from the outside. It is not. GMP-qualified converting plant switchi

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.